Remogliflozin Etabonate in the Treatment of Type 2 Diabetes: Design, Development, and Place in Therapy

Type 2 diabetes mellitus (T2DM) is an emerging epidemic in Asian countries, especially in India. With the advent of the SGLT2 inhibitor class of drugs demonstrating benefits beyond glycemic control, viz. weight loss, blood pressure reduction, and cardiovascular and renal protection, the management o...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohan, Viswanathan, Mithal, Ambrish, Joshi, Shashank R, Aravind, S R, Chowdhury, Subhankar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322139/
https://www.ncbi.nlm.nih.gov/pubmed/32612352
http://dx.doi.org/10.2147/DDDT.S221093

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7322139/
https://www.ncbi.nlm.nih.gov/pubmed/32612352
http://dx.doi.org/10.2147/DDDT.S221093

Ejemplares similares